These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 23408333

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A, Vanderschueren D, Verhaeghe J, Van Asten K, Jans I, Van Herck E, Laenen A, Paridaens R, Billen J, Pauwels S, Vermeersch P, Wildiers H, Christiaens MR, Neven P.
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [Abstract] [Full Text] [Related]

  • 3. Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy.
    Gallicchio L, Macdonald R, Wood B, Rushovich E, Helzlsouer KJ.
    Breast Cancer Res Treat; 2011 Nov; 130(2):569-77. PubMed ID: 21647676
    [Abstract] [Full Text] [Related]

  • 4. Changes in bone biomarker concentrations and musculoskeletal symptoms among breast cancer patients initiating aromatase inhibitor therapy and women without a history of cancer.
    Gallicchio L, MacDonald R, Wood B, Rushovich E, Fedarko NS, Helzlsouer KJ.
    J Bone Miner Res; 2012 Sep; 27(9):1959-66. PubMed ID: 22508239
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A prospective study of aromatase inhibitor therapy, vitamin D, C-reactive protein and musculoskeletal symptoms.
    Helzlsouer KJ, Gallicchio L, MacDonald R, Wood B, Rushovich E.
    Breast Cancer Res Treat; 2012 Jan; 131(1):277-85. PubMed ID: 21904883
    [Abstract] [Full Text] [Related]

  • 7. Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
    Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy SL, Henry NL.
    Clin Breast Cancer; 2018 Apr; 18(2):168-174.e2. PubMed ID: 29361424
    [Abstract] [Full Text] [Related]

  • 8. Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy.
    Sheng JY, Blackford AL, Bardia A, Venkat R, Rosson G, Giles J, Hayes DF, Jeter SC, Zhang Z, Hayden J, Nguyen A, Storniolo AM, Tarpinian K, Henry NL, Stearns V.
    Breast Cancer Res Treat; 2019 Aug; 176(3):617-624. PubMed ID: 31079282
    [Abstract] [Full Text] [Related]

  • 9. Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study.
    Singer O, Cigler T, Moore AB, Levine AB, Hentel K, Belfi L, Do HT, Mandl LA.
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1910-8. PubMed ID: 22730307
    [Abstract] [Full Text] [Related]

  • 10. Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
    Arun B, Valero V, Liu D, Brewster A, Green M, Gutierrez-Barrera A, Akar U, Rivera E, Esteva FJ, Buzdar AU, Hortobagyi GN, Sneige N.
    Cancer Prev Res (Phila); 2012 Feb; 5(2):276-82. PubMed ID: 22102688
    [Abstract] [Full Text] [Related]

  • 11. Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
    Lintermans A, Van Asten K, Jongen L, Van Brussel T, Laenen A, Verhaeghe J, Vanderschueren D, Lambrechts D, Neven P.
    Eur J Cancer; 2016 Mar; 56():31-36. PubMed ID: 26798969
    [Abstract] [Full Text] [Related]

  • 12. Genetic Underpinnings of Musculoskeletal Pain During Treatment With Aromatase Inhibitors for Breast Cancer: A Biological Pathway Analysis.
    Zhu Y, Koleck TA, Bender CM, Conley YP.
    Biol Res Nurs; 2020 Apr; 22(2):263-276. PubMed ID: 31847542
    [Abstract] [Full Text] [Related]

  • 13. A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors.
    Bao T, Cai L, Giles JT, Gould J, Tarpinian K, Betts K, Medeiros M, Jeter S, Tait N, Chumsri S, Armstrong DK, Tan M, Folkerd E, Dowsett M, Singh H, Tkaczuk K, Stearns V.
    Breast Cancer Res Treat; 2013 Feb; 138(1):167-74. PubMed ID: 23393007
    [Abstract] [Full Text] [Related]

  • 14. Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors.
    Olufade T, Gallicchio L, MacDonald R, Helzlsouer KJ.
    Support Care Cancer; 2015 Feb; 23(2):447-55. PubMed ID: 25128067
    [Abstract] [Full Text] [Related]

  • 15. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
    Mouridsen HT.
    Curr Med Res Opin; 2006 Aug; 22(8):1609-21. PubMed ID: 16870085
    [Abstract] [Full Text] [Related]

  • 16. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
    Swenson KK, Nissen MJ, Henly SJ, Maybon L, Pupkes J, Zwicky K, Tsai ML, Shapiro AC.
    Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633
    [Abstract] [Full Text] [Related]

  • 17. Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.
    Perez EA.
    Ann Oncol; 2007 Sep; 18 Suppl 8():viii26-35. PubMed ID: 17890211
    [Abstract] [Full Text] [Related]

  • 18. Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
    Santen RJ.
    J Clin Endocrinol Metab; 2011 Feb; 96(2):308-19. PubMed ID: 21147884
    [Abstract] [Full Text] [Related]

  • 19. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
    Castel LD, Hartmann KE, Mayer IA, Saville BR, Alvarez J, Boomershine CS, Abramson VG, Chakravarthy AB, Friedman DL, Cella DF.
    Cancer; 2013 Jul 01; 119(13):2375-82. PubMed ID: 23575918
    [Abstract] [Full Text] [Related]

  • 20. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ.
    Breast; 2007 Jun 01; 16(3):223-34. PubMed ID: 17368903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.